STEFANIE CAGGIANO: Open Payments
NPI 1104337815 · ZEPHYRHILLS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$310 in 13 payments from 8 companies in 2025. Trend: 2023 $445 · 2024 $472 · 2025 $310
Food & beverage: $310
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 3 | $65 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $50 |
| AngioDynamics, Inc. | 1 | $43 |
| PFIZER INC. | 2 | $38 |
| Alnylam Pharmaceuticals Inc. | 1 | $35 |
| Edwards Lifesciences Corporation | 1 | $32 |
| Amgen Inc. | 2 | $30 |
| AtriCure, Inc. | 1 | $18 |
Products named: Kerendia, AURYON LASER SYSTEM 100-120 VAC, ELIQUIS, ONPATTRO, SAPIEN 3 Ultra RESILIA, REPATHA, LUX-Dx Insertable Cardiac Monitor, WATCHMAN FLX.
Industry payments across FL — which companies pay providers there.
